Amarin Corp Plc (AMRN)

[HDGabor]

BB-

Thanks.

Essentially, Vascepa will never gain the benefits of exclusivity.

Some thoughts:
- V / and AMRN has (will have) all operational benefits from exclusivity: no ANDA till 2020
- maybe (or sure) shareholders have a feeling that they lost something (no BO in 2012 @ $20), but the chance is very good, that it was not a loss, the return could be nice (I mean: $20 in 2012 vs. $30+ (or +/-$50) in 2016) if R-IT will be stopped at interim

It (pps does not affect daily operation) is true for a lot of things.

Best,
G